SLS Sellas Life Sciences

Watchlist

1.110
-0.050-4.31%

Close Mar 28 16:00 ET

1.129
+0.019+1.72%

Post 19:59 ET

100.84MMarket Cap-2.22P/E (TTM)

About Sellas Life Sciences Company

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

Company Profile

SymbolSLS

Company NameSellas Life Sciences

Listing DateMar 12, 2008

Founded2006

CEODr. Angelos M. Stergiou, M.D.

MarketNASDAQ

Employees15

Fiscal Year Ends12-31

AddressTimes Square Tower,7 Times Square,Suite 2503

CityNew York

ProvinceNew York

CountryUnited States of America

Zip Code10036

Phone1-646-200-5278

Websitehttp://www.sellaslifesciences.com

Company Executives

Name
Position
Salary

Dr. Angelos M. Stergiou, M.D.
Director, President and Chief Executive Officer
1.75M

John T. Burns, C.P.A.
Senior Vice President, Finance, Chief Financial Officer and Chief Accounting Officer
783.11K

Dr. Dragan Cicic, M.D.
Senior Vice President and Chief Development Officer
--

Jane Wasman, J.D.
Chairman of the Board
136.28K

Katherine Bach Kalin, M.B.A.
Independent Director
92.50K

Robert L. Van Nostrand
Independent Director
106.28K

John Varian
Independent Director
110.50K

Dr. David A. Scheinberg,M.D.,PhD
Independent Director
102.50K

SLS Sellas Life Sciences

About Sellas Life Sciences Company

Company Profile

Company Executives

Market Insights